Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
Centre for Cancer Outcomes, University College London Hospitals NHS Foundation Trust, London, UK.
BMJ Open. 2023 Apr 19;13(4):e064911. doi: 10.1136/bmjopen-2022-064911.
In the UK, the National Cancer Plan (2000) requires every cancer patient's care to be reviewed by a multidisciplinary team (MDT). Since the introduction of these guidelines, MDTs have faced escalating demands with increasing numbers and complexity of cases. The COVID-19 pandemic has presented MDTs with the challenge of running MDT meetings virtually rather than face-to-face.This study aims to explore how the change from face-to-face to virtual MDT meetings during the COVID-19 pandemic may have impacted the effectiveness of decision-making in cancer MDT meetings and to make recommendations to improve future cancer MDT working based on the findings.
A mixed-methods study with three parallel phases:Semistructured remote qualitative interviews with ≤40 cancer MDT members.A national cross-sectional online survey of cancer MDT members in England, using a validated questionnaire with both multiple-choice and free-text questions.Live observations of ≥6 virtual/hybrid cancer MDT meetings at four NHS Trusts.Participants will be recruited from Cancer Alliances in England. Data collection tools have been developed in consultation with stakeholders, based on a conceptual framework devised from decision-making models and MDT guidelines. Quantitative data will be summarised descriptively, and χ tests run to explore associations. Qualitative data will be analysed using applied thematic analysis. Using a convergent design, mixed-methods data will be triangulated guided by the conceptual framework.The study has been approved by NHS Research Ethics Committee (London-Hampstead) (22/HRA/0177). The results will be shared through peer-reviewed journals and academic conferences. A report summarising key findings will be used to develop a resource pack for MDTs to translate learnings from this study into improved effectiveness of virtual MDT meetings.The study has been registered on the Open Science Framework (https://doi.org/10.17605/OSF.IO/D2NHW).
在英国,《国家癌症计划》(2000 年)要求为每位癌症患者的治疗提供多学科团队(MDT)的审查。自这些指南出台以来,MDT 面临着越来越多和越来越复杂的病例所带来的需求不断增长的挑战。COVID-19 大流行使 MDT 面临着在线而非面对面召开 MDT 会议的挑战。本研究旨在探讨 COVID-19 大流行期间从面对面到虚拟 MDT 会议的转变如何影响癌症 MDT 会议决策的有效性,并根据研究结果提出改善未来癌症 MDT 工作的建议。
这是一项混合方法研究,分为三个平行阶段:
对不超过 40 名癌症 MDT 成员进行半结构化远程定性访谈。
在英格兰对癌症 MDT 成员进行全国性横断面在线调查,使用经过验证的问卷,包括多项选择题和自由文本问题。
在四家 NHS 信托机构观察≥6 次虚拟/混合癌症 MDT 会议。
将从英格兰癌症联盟招募参与者。数据收集工具是在与利益相关者协商的基础上,根据决策模型和 MDT 指南制定的概念框架制定的。定量数据将进行描述性总结,并使用 χ 检验探索关联。定性数据将使用应用主题分析进行分析。使用收敛设计,混合方法数据将根据概念框架进行三角测量。
该研究已获得 NHS 伦理委员会(伦敦-汉普斯特德)(22/HRA/0177)的批准。研究结果将通过同行评议的期刊和学术会议进行分享。一份总结关键发现的报告将用于为 MDT 编制资源包,以便将本研究的经验教训转化为虚拟 MDT 会议的有效性提高。
该研究已在开放科学框架上注册(https://doi.org/10.17605/OSF.IO/D2NHW)。